CENTUPLE GLOBAL last traded at ₹31.92 (2026-10-13). Over the past month the stock moved -11.3%, three months the stock moved -26.6%, year the stock moved -32.0%. Its closing range over 52 weeks is ₹29.26 – ₹126.70, with the latest close 74.8% below the high.
Closing prices up to 2026-10-13.
Incorporated in 1991, Checkpoint Trends Ltd is in the business of trading and consultancy[1]
Business Overview:[1] CTL (Formerly Rubra Medicaments Ltd) was engaged in the manufacture and sale of pharmaceutical formulations based in Hyderabad. The company is currently in the business of trading and providing different kinds of consulting services in India to all categories of clients.
In the latest quarter (Jun 2026), CENTUPLE GLOBAL reported sales of ₹0.00 crore (-100.0%) and net profit of ₹-0.18 crore (-300.0%), compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Jun 2026 | 0.00 | -0.18 | – | -0.18 | -0.33 |
| Mar 2026 | 279.41 | -0.37 | -0.13 | -0.48 | -0.88 |
| Dec 2025 | 174.09 | 0.77 | 0.44 | 0.57 | 1.04 |
| Sep 2025 | 108.59 | 1.80 | 1.66 | 1.32 | 2.41 |
| Jun 2025 | 11.71 | 0.09 | 0.77 | 0.09 | 0.16 |
| Mar 2025 | 0.25 | 0.09 | 36.00 | 0.06 | 0.11 |
| Dec 2024 | 0.10 | -0.04 | -40.00 | -0.02 | -0.04 |
| Sep 2024 | 0.05 | -0.03 | -60.00 | -0.04 | -0.07 |
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | -82.8% | -41.2% | -46.8% | +11610.0% | +217080.0% | +173990.0% | +111664.0% | -100.0% |
| Operating profit growth | -111.5% | -166.7% | – | +200.0% | – | – | -511.1% | -300.0% |
| Net profit growth | -115.4% | -133.3% | – | +350.0% | – | – | -900.0% | -300.0% |
| EPS growth | -114.6% | -136.4% | – | +300.0% | – | – | -900.0% | -306.3% |
| OPM % | -60.0% | -40.0% | 36.0% | 0.8% | 1.7% | 0.4% | -0.1% | – |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
In the latest year (Mar 2026), CENTUPLE GLOBAL reported sales of ₹574.00 crore (+114700.0%) and net profit of ₹2.00 crore (+6566.7%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 574.00 | 2.00 | 0.00 | 2.00 | 2.76 |
| Mar 2025 | 0.50 | 0.06 | 12.00 | 0.03 | 0.05 |
| Mar 2024 | 1.13 | 0.03 | 2.65 | 0.03 | 0.05 |
| Mar 2023 | 1.16 | -0.08 | -6.90 | -0.08 | -0.15 |
| Mar 2022 | 2.01 | -0.02 | -1.00 | -0.04 | -0.07 |
| Mar 2021 | 0.49 | 0.01 | 2.04 | 0.01 | 0.02 |
| Mar 2020 | 0.99 | 0.02 | 2.02 | 0.03 | 0.05 |
| Mar 2019 | 0.59 | -0.18 | -30.51 | -0.01 | -0.02 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | -74.3% | +67.8% | -50.5% | +310.2% | -42.3% | -2.6% | -55.8% | +114700.0% |
| Operating profit growth | – | – | -50.0% | -300.0% | – | – | +100.0% | +3233.3% |
| Net profit growth | – | – | -66.7% | -500.0% | – | – | +0.0% | +6566.7% |
| EPS growth | – | – | -60.0% | -450.0% | – | – | +0.0% | +5420.0% |
| OPM % | -30.5% | 2.0% | 2.0% | -1.0% | -6.9% | 2.7% | 12.0% | 0.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
No AI analysis generated yet for CENTUPLE GLOBAL.
Get Free AI Stock Analysis FREE →No recent news available for CENTUPLE GLOBAL.
CENTUPLE GLOBAL shares were last quoted at ₹31.92 (+4.7% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
CENTUPLE GLOBAL has a price-to-earnings (P/E) ratio of 13.65 and a price-to-book (P/B) ratio of 8.97. The industry P/E is 53.45.
The 52-week high of CENTUPLE GLOBAL is ₹144.40 and the 52-week low is ₹28.42.
The market capitalisation of CENTUPLE GLOBAL is about ₹16.86 crore.
In the latest quarter (Jun 2026), CENTUPLE GLOBAL reported sales of ₹0.00 crore (-100.0%) and net profit of ₹-0.18 crore (-300.0%), compared with the same quarter last year.
This page is for information and is not investment advice. As per the data shown here, CENTUPLE GLOBAL has a 3-year ROE of 12.00%, 3-year profit growth of 175.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
CENTUPLE GLOBAL belongs to the Pharmaceuticals & Drugs sector.